Asahi Kasei Corporation Announces Public Tender Offer to Acquire Calliditas Therapeutics AB (publ)
05/28/24, 7:26 AM
Location
tokyo
stockholmIndustry
health care
pharmaceutical manufacturing
Asahi Kasei Corporation has announced a public tender offer to acquire Calliditas Therapeutics AB (publ), a Swedish biopharmaceutical company specializing in innovative treatments for kidney diseases. The offer involves a cash purchase of shares and American Depositary Shares (ADS) with the aim of expanding Asahi Kasei's presence in the healthcare sector.
Company Info
Location
Tokyo, Tokyo, Japan
Company info
The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 48,000 employees around the world, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care.